SHAREHOLDER ALERT: HPQ JELD BDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

HPQ)

http://www.wongesq.com/pslra-1/hp-inc-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 20, 2020
Class Period: February 23, 2017 to October 3, 2019″ data-reactid=”14″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/hp-inc-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 20, 2020
Class Period: February 23, 2017 to October 3, 2019

According to the filed complaint, defendants knew that HP’s “four-box” model for measuring its supplies business was severely deficient and not a strong predictor of supplies demand and outcomes because HP lacked telemetry data from its commercial printers and had to use unreliable and stagnant market share data to develop assumptions for the four-box model. The complaint further alleges that defendants knew the lack of telemetry data for commercial printing was a critical shortcoming of the four-box model because HP possessed telemetry data on its personal printing side and knew it was a necessary element for an accurate understanding of the supplies channel. As a result, the supplies inventory in the Company’s channel exceeded demand by at least $100 million and HP’s supplies revenue growth was grossly inflated.

More:  Merck, Medtronic, and Other Health-Care Stocks Widely Owned by ESG Funds Outperform

JELD)

http://www.wongesq.com/pslra-1/jeld-wen-holding-inc-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 20, 2020
Class Period: January 26, 2017 to October 15, 2018″ data-reactid=”17″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/jeld-wen-holding-inc-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 20, 2020
Class Period: January 26, 2017 to October 15, 2018

Allegations against JELD include that: (1) the Company’s products, including doors, did not compete against other manufacturers on price, contrary to Jeld-Wen’s representations; (2) the market in which the Company sells its doors is not “highly competitive” as the Company claimed; (3) Jeld-Wen’s strong margins and anticipated margin growth were not, as the Company claimed, attributed to changes they had made in Jeld-Wen’s business operations and strategies; and (4) Jeld-Wen failed to disclose the Company’s anti competitive conduct. Because of the foregoing, Defendants’ statements about the Company’s business, operations and prospects lacked a reasonable basis.

BDX)

http://www.wongesq.com/pslra-1/becton-dickinson-company-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: November 5, 2019 to February 5, 2020″ data-reactid=”20″>If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/becton-dickinson-company-loss-submission-form?prid=6088&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: November 5, 2019 to February 5, 2020

More:  CLASS ACTION UPDATE for QD, WBK and BDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Allegations against BDX include that: (1) certain of Becton’s Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to “make enhancements;” (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

vw@wongesq.com

https://www.accesswire.com/585900/SHAREHOLDER-ALERT-HPQ-JELD-BDX-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

” data-reactid=”27″>

View source version on accesswire.com:
https://www.accesswire.com/585900/SHAREHOLDER-ALERT-HPQ-JELD-BDX-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines


More from: | Category: Medical Device Company News